Madrigal Pharmaceuticals (MDGL) Interest Coverage Ratio Growth (3y) (2013 - 2026)
Madrigal Pharmaceuticals (MDGL) Interest Coverage Ratio Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -42.41% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 28.11% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -6.89% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 79.27% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 29.47% |
| 10 | Madrigal Pharmaceuticals | 15.77 Bn | 15.54 Bn | - | 29.28% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.28% |
| Dec 31, 2025 | 78.71% |
| Sep 30, 2025 | 34.14% |
| Jun 30, 2025 | 45.65% |
| Dec 31, 2023 | -303.29% |
| Sep 30, 2023 | 80.71% |
| Jun 30, 2023 | 89.42% |
| Mar 31, 2023 | 66.40% |
| Dec 31, 2022 | -381.15% |
| Sep 30, 2022 | 38.92% |
| Jun 30, 2022 | 50.27% |
| Dec 31, 2020 | -2.64% |
| Jun 30, 2019 | -304.23% |
| Mar 31, 2019 | -827.51% |
| Dec 31, 2018 | 67.46% |
| Sep 30, 2018 | -120.57% |
| Jun 30, 2018 | 62.54% |
| Dec 31, 2017 | 76.74% |
| Jun 30, 2016 | 72.36% |
| Mar 31, 2016 | 69.11% |